In the process of tumor progression, even though antigen specific T cells can stimulate adaptive immune response, immune selection will also produce tumor cell variants, which will make tumor cells lose major histocompatibility complex (MHC) class I and II antigens expression on their surface as an immune escape mechanism 12. This evidence concerns the gene HLA-C and neoplasm.